IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc., (NYSE:AGN) today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLUMA™ XC, the ...

"SKINVIVE™ by JUVÉDERM ® is a category-creating HA product that leaves skin looking healthier, more glowing, and more hydrated," said Carrie Strom, President, Global Allergan Aesthetics and Senior ...

Hyaluronic acid 25mg/mL, 0.3% w/w lidocaine; injectable gel implant. Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved marketing Juvéderm Vollure XC for correcting moderate-to-severe wrinkles and folds, such as ...

Hyaluronic acid 17.5mg/mL, 0.3% w/w lidocaine; injectable gel implant. Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to ...

SAN DIEGO--(BUSINESS WIRE)--Cearna Aesthetics, an aesthetics company developing plastic surgery and dermatology products, has announced that the U.S. Patent and Trademark Office granted a patent ...